secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2026-06-03T20:30:38+00:00
Accession:  0001104659-26-070126
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sagimet awards 450k options and 450k PSUs to CEO, CFO, and Chief Legal Officer
------------------------------------------------------------------------------

- CEO David Happel receives 300,000 options and 300,000 PSUs at $7.27 exercise price.
- CFO Thierry Chauche receives 50,000 options and 50,000 PSUs; Chief Legal Officer Elizabeth Rozek receives 100,000 each.
- Options vest over 48 months; PSUs tied to regulatory milestones with one-third cliff vest at achievement date.
- PSU award form filed as Exhibit 10.1; grants under 2023 Stock Option and Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465926070126/0001104659-26-070126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465926070126/tm2616747d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-070126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer